PROCEPT BioRobotics Corporation Operating Lease, Liability, Current
PROCEPT BioRobotics Corporation (PRCT) had Operating Lease, Liability, Current of $2.50 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Current $2.50M.
- 2026-03-31: Operating Lease, Liability, Current $2.36M.
- 2025-12-31: Operating Lease, Liability, Current $2.21M.
- 2025-09-30: Operating Lease, Liability, Current $2.13M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $2.50M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $2.36M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $2.21M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $2.13M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.06M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.98M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $1.91M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.84M 10-Q · filed 2024-10-28 |
| 2024-06-30 | $1.77M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $1.70M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.68M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.35M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $3.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.13M 10-K · filed 2024-02-28 |
| 2022-09-30 | $2.47M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $2.26M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $2.18M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $2.10M 10-K · filed 2023-02-28 |
| 2021-09-30 | $2.03M 10-Q · filed 2021-11-05 |
| 2020-12-31 | $1.71M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |